References:
- Ross JR, Puga TA, & Philbeck TE. Longitudinal dialysis adequacy and clinical performance
of the VectorFlow hemodialysis catheter: a prospective study. J Vasc Access.
2017;18(6):492-497. Study sponsored by Teleflex. Ross JR was formerly a paid consultant of
Teleflex. Puga TA and Philbeck TE are employees of Teleflex.
- Data on file at Teleflex. Test data may not be indicative of clinical performance.
- Nobili M, Sheriff J, Morbiducci U, et al. Platelet activation due to hemodynamic shear
stresses: damage accumulation model and comparison to in-vitro measurements. ASAIO J.
2008;54(1):64-72.
- Data on file at Teleflex. Test data may not be indicative of clinical performance.
- Clark TWI, Isu G, Gallo D, et al. Comparison of symmetric hemodialysis catheters using
computational fluid dynamics. J Vasc Interv Radiol. 2015;26(2):252-259. Data on file
at Teleflex. Computer modeling may not be indicative of clinical performance. Timothy Clark,
MD, is a paid consultant and receives royalty payments from Teleflex or its affiliates for the
Arrow-Clark VectorFlow Chronic Hemodialysis Catheter.
- National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice
recommendations. Guideline 7: Prevention and treatment of catheter and port complications.
2006 update. Am J Kidney Dis. 2006;48:1-322.
The Arrow-Clark™ VectorFlow® Antegrade
Catheter is indicated for use in attaining long-term vascular access for hemodialysis and
apheresis. The Arrow-Clark™ VectorFlow® Antegrade Catheter is
inserted percutaneously and is preferentially placed into the internal jugular (IJ) vein.
Alternately, this catheter may be inserted into the subclavian vein although the jugular vein is
the preferred site. Catheters greater than 40 cm are intended for femoral vein insertion. The
Arrow-Clark™ VectorFlow® Antegrade Catheter is intended for use in
adult patients.
The Arrow-Clark™ VectorFlow® Retrograde Catheter is indicated for
use in attaining long-term vascular access for hemodialysis and apheresis. The
Arrow-Clark™ VectorFlow® Retrograde Catheter is inserted
percutaneously and is preferentially placed into the internal jugular (IJ) vein. Alternately, this
catheter may be inserted into the subclavian vein although the jugular vein is the preferred site.
Catheters greater than 40 cm are intended for femoral vein insertion. The
Arrow-Clark™ VectorFlow® Retrograde Catheter is intended for use
in adult patients.
Refer to the Instructions for Use for a complete listing of the indications, contraindications,
warnings and precautions. Information in this material is not a substitute for the product
Instructions for Use.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Not all products are available in all regions. Please contact customer service to confirm
availability in your region.
VectorFlow is a registered trademark of Aegis Medical Technologies LLC.
Teleflex, the Teleflex logo and Arrow-Clarke are trademarks or registered trademarks of Teleflex
Incorporated or its affiliates, in the U.S. and/or other countries. MC-004319 Rev 2
Revised: 09/2021.